Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment

Transplantation

Volumn 66, Issue 10, 1998, Pages 1387-1388

  Li, Yongsheng ^a   Zheng, Xin Xiao ^a   Li, Xian Chang ^a   Zand, Martin S ^a   Strom, Terry B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; RAPAMYCIN;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECIPIENT; T LYMPHOCYTE ACTIVATION;

EID: 0345164351     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199811270-00021     Document Type: Article

References (8)

1. Linsley PS, Brady W, Urnes M, et al. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174: 561.
2. Noelle RJ, Roy M, Shepherd DM, et al. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 1992; 89: 6550.
3. Turka LA, Linsley PS, Lin H, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992; 89: 11102.
4. Parker DC, Greiner DL, Phillips NE, et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 1995; 92: 9560.
5. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD-gp39 interactions play a critical role during allograft rejection. suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 1996; 61: 4.
6. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathway. Nature 1996; 381: 434.
7. Li XC, Zheng XX, Strom TB. T cell growth factors in allograft rejection and tolerance. Transplant Proc, in press.
8. Corry RJ, Winn HJ, Russell PS, et al. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343.